Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Loconsole

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Italian Journal of Dermatology and Venereology|January 27, 2025
Efficacy and safety of treatment with biological drugs in psoriasis patients with a history of malignancies: a single-center observational studyEdoardo Mortato, Giorgia Sbarra, Riccardo Viola, et al.
The Journal of Dermatological Treatment|January 30, 2016
Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian studyAntonio Carpentieri, Lucia Pacello, Immacolata Maria De Marco, et al.
Dermatologic Therapy|July 23, 2020
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life studyAntonio Carpentieri, Paola Mascia, Marco Fornaro, et al.
Rheumatology and Immunology Research|April 4, 2024
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigationMarco Matucci-Cerinic, Francesco Ciccia, Rosario Foti, et al.
The Journal of Dermatological Treatment|April 6, 2022
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infectionMatteo Megna, Cataldo Patruno, Maria Rita Bongiorno, et al.
Clinical Drug Investigation|May 28, 2022
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C InfectionMatteo Megna, Cataldo Patruno, Maria Rita Bongiorno, et al.
Italian Journal of Dermatology and Venereology|January 10, 2022
Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centersFrancesco Messina, Mario Valenti, Piergiorgio Malagoli, et al.
Journal of Dermatological Science|February 16, 2015
Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysisLeonardo Pescitelli, Valentina Dini, Paolo Gisondi, et al.
Acta Dermato-Venereologica|May 18, 2017
Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian ExperienceFederico Bardazzi, Michela Magnano, Anna Campanati, et al.
The Journal of Dermatological Treatment|February 23, 2026
Toward the definition of moderate psoriasis: an expert opinionAntonio Costanzo, Federico Bardazzi, Martina Burlando, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Italian Journal of Dermatology and Venereology|January 27, 2025
Efficacy and safety of treatment with biological drugs in psoriasis patients with a history of malignancies: a single-center observational studyEdoardo Mortato, Giorgia Sbarra, Riccardo Viola, et al.
The Journal of Dermatological Treatment|January 30, 2016
Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian studyAntonio Carpentieri, Lucia Pacello, Immacolata Maria De Marco, et al.
Dermatologic Therapy|July 23, 2020
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life studyAntonio Carpentieri, Paola Mascia, Marco Fornaro, et al.
Rheumatology and Immunology Research|April 4, 2024
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigationMarco Matucci-Cerinic, Francesco Ciccia, Rosario Foti, et al.
The Journal of Dermatological Treatment|April 6, 2022
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infectionMatteo Megna, Cataldo Patruno, Maria Rita Bongiorno, et al.
Clinical Drug Investigation|May 28, 2022
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C InfectionMatteo Megna, Cataldo Patruno, Maria Rita Bongiorno, et al.
Italian Journal of Dermatology and Venereology|January 10, 2022
Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centersFrancesco Messina, Mario Valenti, Piergiorgio Malagoli, et al.
Journal of Dermatological Science|February 16, 2015
Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysisLeonardo Pescitelli, Valentina Dini, Paolo Gisondi, et al.
Acta Dermato-Venereologica|May 18, 2017
Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian ExperienceFederico Bardazzi, Michela Magnano, Anna Campanati, et al.
The Journal of Dermatological Treatment|February 23, 2026
Toward the definition of moderate psoriasis: an expert opinionAntonio Costanzo, Federico Bardazzi, Martina Burlando, et al.
Pageof 8